Loading…
Lobbying Spend
—
Filings
11
Firms Hired
1
Active Period
2021–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
STATES 2.0 Act
2024 · first_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Client expense: — · Firm income: $40,000
Matched citations: H.R.6673
STATES 2.0 Act
2023 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization and regulation; H.R.6673 - STATES 2.0 Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.6673
SAFE Banking Act of 2021
2022 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.1996
Marijuana Opportunity Reinvestment and Expungement Act
2022 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.3617
Medical Marijuana Research Act
2022 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5657
Cannabidiol and Marihuana Research Expansion Act
2022 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: S.253
Cannabis Administration and Opportunity Act
2022 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: S.4591
SAFE Banking Act of 2021
2022 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: S.910
SAFE Banking Act of 2021
2022 · third_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.1996
Marijuana Opportunity Reinvestment and Expungement Act
2022 · third_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.3617
Medical Marijuana Research Act
2022 · third_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5657
Cannabidiol and Marihuana Research Expansion Act
2022 · third_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: S.253
Cannabis Administration and Opportunity Act
2022 · third_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: S.4591
SAFE Banking Act of 2021
2022 · third_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; S.4591 - Cannabis Administration and Opportunity Act, S.910 - SAFE Banking Act of 2021, H.R.1996 - SAFE Banking Act of 2021, H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act
Client expense: — · Firm income: $60,000
Matched citations: S.910
Marijuana Opportunity Reinvestment and Expungement Act
2022 · second_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act (MORE) Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.3617
Medical Marijuana Research Act
2022 · second_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act (MORE) Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5657
Cannabidiol and Marihuana Research Expansion Act
2022 · second_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act (MORE) Act
Client expense: — · Firm income: $60,000
Matched citations: S.253
Marijuana Opportunity Reinvestment and Expungement Act
2022 · first_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act (MORE) Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.3617
Medical Marijuana Research Act
2022 · first_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act (MORE) Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.5657
Cannabidiol and Marihuana Research Expansion Act
2022 · first_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Cannabis legalization, regulation, and research, generally; S.253 - Cannabidiol and Marihuana Research Expansion Act; H.R.5657 - Medical Marijuana Research Act; H.R.3617 - Marijuana Opportunity Reinvestment and Expungement Act (MORE) Act
Client expense: — · Firm income: $60,000
Matched citations: S.253
Veterans Medical Marijuana Safe Harbor Act.
2021 · fourth_quarter · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
S.1183 - Veterans Medical Marijuana Safe Harbor Act
Client expense: — · Firm income: $60,000
Matched citations: S.1183
Source: Senate LDA